Inflammatory cell activation by eosinophil granule proteins.
Thomas
L L
LL
Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Ill., USA. lthomas2@rush.edu
Page
S M
SM
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects; D001798:Blood Proteins / Q000494:pharmacology*; D002118:Calcium / Q000502:physiology; D004730:Endothelium, Vascular / Q000187:drug effects; D047091:Eosinophil Granule Proteins; D047209:Eosinophil Peroxidase; D047208:Eosinophil-Derived Neurotoxin; D006098:Granulocytes / Q000187:drug effects*; D006801:Humans; D010544:Peroxidases / Q000494:pharmacology*; D011494:Protein Kinases / Q000502:physiology; D011506:Proteins / Q000494:pharmacology*; D012260:Ribonucleases; D014158:Transcription, Genetic
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D011506:Proteins; D047209:Eosinophil Peroxidase; D010544:Peroxidases; D011494:Protein Kinases; D047208:Eosinophil-Derived Neurotoxin; D012260:Ribonucleases; D002118:Calcium